As deadline nears, global pandemic treaty talks hobbled by delays and quarrels [Globe and Mail, The (Toronto, Canada)]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Globe and Mail, The
Governments are squabbling over almost every line in the latest 110-page draft of the proposed agreement. There are almost 5,000 brackets in the latest version, with each of the brackets signalling objections or caveats by various countries. To worsen the situation, the treaty has been dogged by persistent conspiracy theories and disinformation campaigns on social media, including the false claim that it would create a global regime with the power to use military force to impose lockdowns and eliminate freedoms. This has eroded the political support that the treaty needs, analysts say. The negotiations over the past 28 months have been tortuous. But after nine rounds of backroom talks by the World Health Organization 's member states, a deadline is approaching soon. Under the official schedule, the WHO needs an agreement by May 27, the beginning of this year's World Health Assembly in Geneva. If there is no deal by then, the treaty will be left in limbo. A last-ditch round of
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at Royal Bank of Canada from $125.00 to $135.00. They now have an "outperform" rating on the stock.MarketBeat
- Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at Oppenheimer Holdings Inc. from $142.00 to $163.00. They now have an "outperform" rating on the stock.MarketBeat
- Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening? [The New York Times]The New York Times
- Moderna reports $1.2bn net loss in Q1 2024 [Yahoo! Finance]Yahoo! Finance
- Moderna's sales from its only product, the COVID-19 vaccine, fell 91% from last year [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 5/1/24 - Form 144
- MRNA's page on the SEC website